Human Subjects Research Guidelines

Comprehensive ethical standards and IRB requirements for clinical research involving human participants

Overview

WiseLeaf Scientific Ventures is committed to upholding the highest ethical standards in human subjects research. All manuscripts involving human participants must demonstrate compliance with established ethical principles and regulatory requirements. This page outlines the fundamental requirements for conducting and reporting research involving human subjects.

Fundamental Ethical Principles

Respect for Persons

  • Individuals must be treated as autonomous agents capable of making informed decisions
  • Persons with diminished autonomy are entitled to additional protections
  • Informed consent must be obtained from all participants or their legal representatives
  • Participants must have the right to withdraw from research at any time without penalty
  • Privacy and confidentiality of participant information must be maintained

Beneficence and Non-Maleficence

  • Research must maximize potential benefits while minimizing risks to participants
  • Risk-benefit analysis must be conducted and documented
  • Risks must be reasonable in relation to anticipated benefits
  • Procedures for monitoring participant safety must be established
  • Adverse events must be reported according to institutional and regulatory guidelines

Justice

  • Fair selection of research participants based on scientific objectives
  • Vulnerable populations should not bear undue burden of research participation
  • Benefits of research should be fairly distributed
  • Special considerations for vulnerable populations (children, pregnant women, prisoners, etc.)
  • Cultural sensitivity and inclusivity in research design and conduct

Institutional Review Board (IRB) Requirements

IRB Approval Process

  • All human subjects research must receive IRB approval before initiation
  • Research protocol must be submitted with complete documentation
  • Informed consent forms must be reviewed and approved
  • Continuing review is required for ongoing studies
  • Modifications to approved protocols require IRB review
  • Final study reports must be submitted upon completion

Documentation Requirements

Manuscripts must include the IRB approval number, institution name, and approval date. For international studies, equivalent ethics committee approval must be documented. Studies conducted before current ethical standards may require additional justification.

Informed Consent Standards

Essential Elements of Informed Consent

  • Clear explanation of research purpose, procedures, and duration
  • Description of reasonably foreseeable risks and discomforts
  • Description of potential benefits to participants and society
  • Disclosure of appropriate alternative procedures or treatments
  • Statement of confidentiality protections and data use
  • Contact information for questions about research and participants' rights
  • Statement that participation is voluntary and withdrawal is permitted
  • Information about compensation and treatment for research-related injuries

Special Considerations

  • Consent forms must be written in language understandable to participants
  • Translation and back-translation required for non-English speaking populations
  • Cultural adaptations while maintaining essential elements
  • Assent procedures for minors with parental permission
  • Capacity assessment for participants with cognitive impairment
  • Documentation requirements and waiver conditions

Data Protection and Privacy

Data Security Measures

  • Secure data collection, storage, and transmission protocols
  • De-identification procedures for participant data
  • Access controls and user authentication systems
  • Data backup and recovery procedures
  • Compliance with applicable privacy regulations (HIPAA, GDPR, etc.)
  • Data retention and destruction timelines

Data Sharing Guidelines

When sharing de-identified data, researchers must ensure that re-identification is not reasonably feasible. Data sharing agreements should specify permitted uses, security requirements, and prohibitions on re-identification attempts.

Research with Vulnerable Populations

Pediatric Research

  • Risk categories and regulatory approval requirements
  • Assent procedures appropriate for child's age and maturity
  • Parental permission requirements and exceptions
  • Age-appropriate study materials and procedures
  • Special protections for adolescent participants

Pregnant Women and Reproductive Health

  • Risk assessment for pregnant women and fetuses
  • Pregnancy testing and contraception requirements
  • Involvement of partners in consent process when appropriate
  • Special considerations for research during labor and delivery
  • Neonatal research protections

Other Vulnerable Groups

  • Prisoners: Additional regulatory requirements and restrictions
  • Cognitively impaired individuals: Capacity assessment and surrogate consent
  • Economically disadvantaged populations: Avoiding undue inducement
  • Students and employees: Minimizing coercion and undue influence
  • Indigenous communities: Cultural protocols and community engagement

International and Multi-Site Research

Cross-Cultural Considerations

  • Respect for local customs, laws, and ethical standards
  • Community engagement and partnership principles
  • Fair distribution of research benefits to study communities
  • Capacity building and knowledge transfer obligations
  • Post-study access to successful interventions
  • Collaborative oversight and monitoring mechanisms

Collaborative Review

Multi-site studies may use centralized IRB review or site-specific review. Each site must ensure compliance with local regulations and cultural norms while maintaining scientific integrity across sites.

Manuscript Reporting Requirements

Ethical Statement

  • IRB/Ethics committee approval number and institution
  • Date of approval and any amendments
  • Statement of compliance with ethical principles (Declaration of Helsinki)
  • Informed consent process description
  • Any special ethical considerations or approvals
  • Conflict of interest disclosures

Study Conduct Reporting

  • Participant recruitment and screening procedures
  • Randomization and blinding procedures (if applicable)
  • Adverse event reporting and safety monitoring
  • Protocol deviations and their management
  • Data monitoring committee oversight (if applicable)
  • Study termination criteria and actual outcomes

Additional Resources

Declaration of Helsinki

World Medical Association's ethical principles for medical research involving human subjects

Read Guidelines

Good Clinical Practice

ICH E6 guidelines for design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials

View ICH Guidelines

Regulatory Resources

FDA and international regulatory guidance for human subjects research

Access Resources

Questions About Human Subjects Research?

Our editorial team is available to assist with questions about ethical requirements and reporting standards.

Contact Ethics Committee